Kagiyama, Y., Fujita, S., Shima, Y., Yamagata, K., Katsumoto, T., Nakagawa, M., . . . Kitabayashi, I. (2021). CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib. Cancer Sci.
Chicago ZitierstilKagiyama, Yuki, et al. "CDKN1C‐mediated Growth Inhibition By an EZH1/2 Dual Inhibitor Overcomes Resistance of Mantle Cell Lymphoma to Ibrutinib." Cancer Sci 2021.
MLA ZitierstilKagiyama, Yuki, et al. "CDKN1C‐mediated Growth Inhibition By an EZH1/2 Dual Inhibitor Overcomes Resistance of Mantle Cell Lymphoma to Ibrutinib." Cancer Sci 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.